Skip to main navigation Skip to search Skip to main content

A Phase 3, Open-label Study Evaluating the Long term Safety of VX-445 Combination Therapy in Subjects with Cystic Fibrosis

Upstate Medical University

Project: Research

Project Details

StatusFinished
Effective start/end date12/9/19 → 12/8/24

Funding

  • Vertex Pharmaceuticals Incorporated: $209,371.00